SUMMARY A computer programme is presented for calculating the recurrence risk in X linked disorders, combining pedigree and DNA probe data with other conditional information such as carrier detection tests. The methods of computation are shown in the given examples. The programme can be used with either a single DNA probe or two 'flanking' DNA probes for both familial and isolated case pedigrees. For isolated case families the mutation rate at the disease locus can be taken into account in conjunction with the DNA probe data.
In recent years more than 200 DNA polymorphisms have been characterised in man,' and there is no doubt that the number required2 3 to span the human genome will soon be reached. This has increased the power of linkage analysis for prediction of genetic diseases, especially X linked diseases, such as Duchenne (DMD) and Becker (BMD) muscular dystrophy.4 Before linkage was shown in these diseases with various DNA markers,5 6 estimation of recurrence risk for subjects at risk was limited to analysis of the pedigree structure together with any tests of carrier status available. The estimation of risk in large families can be complex and prone to error. A computer programme7 (PEDIG) has helped to overcome the problem and can handle the additional information produced when carrier detection tests (for example, CK levels) are used. Recently, the use of linked DNA markers in genetic counselling has also been shown to be a valuable means of altering the risk of individuals.89 However, the combined use of pedigree information, carrier detection tests, and DNA analysis is complex and mistakes are made easily. A computer programme (LINKAGE) has recently been introduced,'( which can handle complex pedigrees, using linked DNA markers and CK information. However, the use of this programme has proved to be difficult for clinicians with no computing experience, and the programme still needs to be tested further. The present paper describes a simple (2-72%) , as she has inherited alleles 2 for both markers from her mother. In the absence of a double crossover between the disease and the DNA markers, she would have inherited the normal gene at the disease locus from her mother. In this example the information from the other sib is not used because the phase of the disease with respect to both markers is known. Here, the prior risk for the consultand of 50% has been changed to 2-72%, which is substantially lower. This result can be further modified by information from carrier detection tests. The CK testing for the consultand provides a likelihood ratio of 0 12:1 of being a carrier-at her age and CK level. Combining this with DNA analysis would give her a final risk of 0-33% for being a carrier. EXAMPLE 2 A more complicated situation arises when the phase of the DNA markers with the disease gene is not known. The phase of the disease in the mother with the marker alleles can be calculated, using the genotypes of her offspring. The odds of the disease and marker alleles being in coupling in the mother 'M' are first estimated, and then the probability of the consultand 'C' being a carrier is computed. Again this estimation can be modified by additional information from carrier detection tests (CK) and her normal son. For O1=0 16 and R,=0 12 and CK likelihood of 0-44:1 for being a carrier, the calculations are given in table 1. EXAMPLE 3 In this example the phase of the disease with the DNA marker is unknown, and there are no sibs from which to estimate the odds of coupling in the consultand's mother. However, information for the uncle of the consultand is available and can be used to determine the likelihood of her being a carrier. The recurrence risk in the consultand will vary, depending on the gene frequencies of the DNA marker (with rare allele frequency of 'f'). In this situation all the possible genotypes for the grandparents have to be considered; from this the odds of coupling in the mother 'M' are estimated and applied to compute the final risk in the consultand 'C'. A summary of this approach is given in table 2 for 0=0*15 and f=0-11.
When the grandfather's DNA is 1, the odds of the mother 'M' having the disease gene and allele 2 (of the DNA marker) on the same chromosome are (0-0630 + 0-0020 + 0-0108)/0.0786=0.9644, and, similarly, when the grandfather's DNA genotype is 2, the odds of the mother having the disease gene and allele 1 on the same chromosome are (0.0014 + 0-0014)/0-0786=0-0356.
The probability of recurrence risk in the consultand is now equal to (1-) x 0-9644 + 0 x 0-0356=0*8251. EXAMPLE 4 This is an isolated case of Duchenne muscular dystrophy (DMD) with four normal sons and two 
In mother 'M' odds of coupling with the DNA allele 2 is: (0-0630+0((X)2+0 (0108) H=recombination frequency between the disease and the DNA marker loci (H=(0-15). Here the information anterior to the consultand 'C' can be used to predict the likelihood for the mother 'M' being a carrier, incorporating pedigree data and CK levels from both mother and grandmother. This information is then combined with the DNA analysis and the CK likelihood of the consultand to achieve the final risk estimate. Probability that consultand is a carrier: 0-102 + 0-007=0-109 and the probability that she is not a carrier: 0-237 + 0-102 + 0-552=0-891. EXAMPLE 5 This is a pedigree in which the consultand is the aunt of the living affected male. DNA information from group.bmj.com on June 21, 2017 -Published by http://jmg.bmj.com/ Downloaded from the affected male's mother is combined with that obtained from the aunt's sibs (and their children) to derive a provisional risk for the consultand. Finally, the information from carrier detection tests and DNA information from the consultand's children is used to derive the final risk for her. The summary of this approach for H =0-15 and 02=0-10 is shown in table 4.
Discussion
The calculation of recurrence risks, using pedigree data and conditional information from CK levels and healthy sons, can present difficulties. The computation is even more complex when DNA data are included and especially when a new mutation at the disease locus is a possibility. An obvious solution to this problem is a computer programme.
This paper describes an interactive programme (RISKDNA) which is easy to use and does not require computing experience to understand or to operate (see appendix for illustrations of data entry and output for example 1). This programme prompts the user for each item of information and, depending on the type of pedigree data, the logic and order of the questions will vary. The programme will then call for the appropriate subroutine and at the end displays the final risk on the screen. The details of the analysis can also be displayed.
This programme can be used for any X linked disease, using either one single DNA marker, or two 'flanking' DNA markers each with two codominant alleles. The programme can incorporate information from pedigree data (for both familial and isolated cases), DNA analysis, and carrier detection tests (such as CK levels). The RISKDNA programme can be used for one or two 'flanking' DNA markers in phase known (see example 1) and phase unknown pedigrees (see example 2), or when the only information available is on the uncle of the consultand (see example 3).
It is also possible to incorporate DNA data into the estimation of risk for sisters (see example 4), mothers, aunts, and grandmothers of isolated cases. In the case of 'flanking' markers, if the phase is only known for one probe, the programme uses the information on sibs to estimate the odds of coupling in the mother of the consultand for the second marker.
If the consultand is the aunt of the affected male, then the programme combines the DNA information from the affected male's sibs with the DNA information from the consultand's sibs (and their children) to estimate the recurrence risk for the consultand. This is further modified by DNA information from her children and the result of any carrier detection tests (see example 5) .
It is hoped that the approach and the programme described here will help those involved in genetic counselling, who have little or no experience in computing, by enabling them to estimate recurrence risks in families with X linked disorders without having to go through lengthy mathematical calculations. The programme RISKDNA is freely available to the interested reader, and can be supplied on IBM 51/4" floppy disks. Suggestions for improvement of the programme from users will be particularly welcome. 
